NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported 14 percent growth in revenues year over year for the first quarter as the Analytical Technologies and Specialty Diagnostics segments each grew more than 20 percent.

For the period ended March 31, total revenues rose to $3.10 billion from $2.72 billion, besting Wall Street estimates of $2.98 billion.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.